Development of a Novel Tool for the Retrieval and Analysis of Hormone Receptor Expression Characteristics in Metastatic Breast Cancer via Data Mining on Pathology Reports

被引:1
|
作者
Chang, Kai-Po [1 ,2 ]
Wang, John [2 ]
Chang, Chi-Chang [3 ,4 ]
Chu, Yen-Wei [5 ,6 ,7 ,8 ,9 ,10 ]
机构
[1] Natl Chung Hsing Univ, PhD Program Med Biotechnol, Taichung 402, Taiwan
[2] China Med Univ Hosp, Dept Pathol, Taichung 404, Taiwan
[3] Chung Shan Med Univ, Sch Med Informat, Taichung 402, Taiwan
[4] Chung Shan Med Univ Hosp, IT Off, Taichung 402, Taiwan
[5] Natl Chung Hsing Univ, Inst Genom & Bioinformat, 145 Xingda Rd, Taichung 402, Taiwan
[6] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 402, Taiwan
[7] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 402, Taiwan
[8] Natl Chung Hsing Univ, Biotechnol Ctr, Taichung 402, Taiwan
[9] Natl Chung Hsing Univ, PhD Program Translat Med, Taichung 402, Taiwan
[10] Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung 402, Taiwan
关键词
PROGESTERONE-RECEPTOR; ESTROGEN-RECEPTOR; AMERICAN SOCIETY; IMMUNOHISTOCHEMISTRY; TEXT; RECOMMENDATIONS; POPULATION; PATHWAY;
D O I
10.1155/2020/2654815
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Information about the expression status of hormone receptors such as estrogen receptor (ER), progesterone receptor (PR), and Her-2 is crucial in the management and prognosis of breast cancer. Therefore, the retrieval and analysis of hormone receptor expression characteristics in metastatic breast cancer may be valuable in breast cancer study. Herein, we report a text mining tool based on word/phrase matching that retrieves hormone receptor expression data of regional or distant metastatic breast cancer from pathology reports. It was tested on pathology reports at the China Medical University Hospital from 2013 to 2018. The tool showed specificities of 91.6% and 63.3% for the detection of regional lymph node metastasis and distant metastasis, respectively. Sensitivity in immunohistochemical study result extraction in these cases was 98.6% for distant metastasis and 78.3% for regional lymph node metastasis. Statistical analysis on these retrieved data showed significant difference s in PR and Her-2 expressions between regional and metastatic breast cancer, which is compatible with previous studies. In conclusion, our study shows that metastatic breast cancer hormone receptor expression characteristics can be retrieved by text mining. The algorithm designed in this study may be useful in future studies about text mining in pathology reports.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Real world data analysis of next generation sequencing and protein expression in metastatic breast cancer patients
    Hempel, Dirk
    Ebner, Florian
    Garg, Arun
    Trepotec, Zeljka
    Both, Armin
    Stein, Werner
    Gaumann, Andreas
    Guettler, Lucia
    Janni, Wolfgang
    DeGregorio, Amelie
    Hempel, Louisa
    Milani, Valeria
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [32] Real world data analysis of next generation sequencing and protein expression in metastatic breast cancer patients
    Dirk Hempel
    Florian Ebner
    Arun Garg
    Zeljka Trepotec
    Armin Both
    Werner Stein
    Andreas Gaumann
    Lucia Güttler
    Wolfgang Janni
    Amelie DeGregorio
    Louisa Hempel
    Valeria Milani
    Scientific Reports, 10
  • [33] Clinicopathological characteristics, evolution, treatment patterns and outcomes of hormone-receptor-positive/HER2-low-positive metastatic breast cancer: A retrospective analysis
    Wang, Biyun
    You, Shuhui
    Zhao, Yannan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [34] Hormone receptor status, erbB2 expression and cancer stem cell characteristics of circulating tumor cells in breast cancer patients
    Rack, Brigitte
    Bock, Carolin
    Andergassen, Ulrich
    Doisneau-Sixou, Sophie
    HISTOLOGY AND HISTOPATHOLOGY, 2012, 27 (07) : 855 - 864
  • [35] Current and Novel Treatment Options in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer
    Lopetegui-Lia, Nerea
    Varma, Revati
    Abraham, Jame
    Roesch, Erin
    JCO ONCOLOGY PRACTICE, 2025, 21 (02)
  • [36] Markers of Metastatic Breast Cancer: Correlations between GCDFP-15 or Mammaglobin Expression and Tumor Grade, Hormone Receptor, and HER2 Expression
    Gown, A. M.
    Goldstein, L. C.
    Kandalaft, P. L.
    Hwang, H. C.
    Kussick, S. J.
    Tse, C. C.
    MODERN PATHOLOGY, 2010, 23 : 48A - 48A
  • [37] Markers of Metastatic Breast Cancer: Correlations between GCDFP-15 or Mammaglobin Expression and Tumor Grade, Hormone Receptor, and HER2 Expression
    Gown, A. M.
    Goldstein, L. C.
    Kandalaft, P. L.
    Hwang, H. C.
    Kussick, S. J.
    Tse, C. C.
    LABORATORY INVESTIGATION, 2010, 90 : 48A - 48A
  • [38] Estrogen receptor expression and docetaxel efficacy in patients with metastatic breast cancer: A pooled analysis of four randomized trials
    Mazouni, C.
    Andre, F.
    Broglio, K.
    Pusztai, L.
    Hortobagyi, G. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [39] Estrogen Receptor Expression and Docetaxel Efficacy in Patients with Metastatic Breast Cancer: A Pooled Analysis of Four Randomized Trials
    Andre, Fabrice
    Broglio, Kristine
    Pusztai, Lajos
    Berrada, Narjiss
    Mackey, John R.
    Nabholtz, Jean Marc
    Chan, Stephen
    Hortobagyi, Gabriel N.
    ONCOLOGIST, 2010, 15 (05): : 476 - 483
  • [40] Clinicopathological characteristics, evolution, treatment pattern and outcomes of hormone-receptor-positive/HER2-low metastatic breast cancer
    You, Shuhui
    Gong, Chengcheng
    Li, Yi
    Xie, Yizhao
    Li, Yumeng
    Zhao, Yannan
    Wang, Biyun
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14